Trial Profile
A study evaluating efficacy of Nitazoxanide for the treatment of resistant Clostridium difficile Colitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2018
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Clostridium difficile infections; Colitis
- Focus Therapeutic Use
- 06 Feb 2018 New trial record.